Aethlon Medical News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.05.24	Aethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results (RTTNews)
21.02.24	Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices (RTTNews)
14.11.23	Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
13.11.23	Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (PR Newswire)
06.11.23	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 (PR Newswire)
10.10.23	Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology (PR Newswire)
04.10.23	Aethlon Announces Reverse Stock Split (PR Newswire)
30.08.23	Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
10.08.23	Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update (PR Newswire)
03.08.23	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 (PR Newswire)
24.07.23	Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant (PR Newswire)
06.07.23	Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors (PR Newswire)
28.06.23	Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire)
22.06.23	Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 (PR Newswire)
21.06.23	Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation (PR Newswire)
14.06.23	Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest (PR Newswire)
01.06.23	Aethlon Medical to Present at the 13th Annual LD Micro Invitational (PR Newswire)
22.05.23	Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India (PR Newswire)
13.02.23	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
31.01.23	Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023 (PR Newswire)
30.01.23	Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer (PR Newswire)
14.11.22	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
02.11.22	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 (PR Newswire)
06.09.22	Aethlon Medical to Present at Two Investor Conferences in September (PR Newswire)
09.08.22	Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update (PR Newswire)
03.08.22	Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022 (PR Newswire)
28.07.22	Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants (PR Newswire)
11.07.22	FDA Approves Aethlon Medical's Protocol Amendment For COVID-19 Trial (RTTNews)
11.07.22	Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment (PR Newswire)
28.06.22	Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update (PR Newswire)
21.06.22	Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022 (PR Newswire)
17.05.22	Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference (PR Newswire)
02.05.22	Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants (PR Newswire)
28.03.22	Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors (PR Newswire)
14.02.22	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
31.01.22	Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022 (PR Newswire)
09.11.21	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
02.11.21	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021 (PR Newswire)
12.10.21	Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier® (PR Newswire)
30.09.21	Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs (PR Newswire)
09.09.21	Pre-market Movers: HGEN, PMCB, CRDF, HLBZ, LULU… (RTTNews)
07.09.21	Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
04.01.21	Pre-market Movers In Healthcare Sector: OCGN, BNGO, JAGX, IMMP, SLLS… (RTTNews)
16.12.20	Stock Alert: Aethlon Medical Jumps 45% (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
19.06.20	FDA Nod For EPZM, RARE, Court Rules In MYL's Favor, Ocuphire To Hop Onto Nasdaq, ALPN Soars (RTTNews)
18.06.20	Stock Alert: Aethlon Medical Surges After FDA Okays Hemopurifier Testing For COVID-19 (RTTNews)
18.06.20	Aethlon Medical: FDA Allows Testing Of Hemopurifier In COVID-19; Shares Surge (RTTNews)
28.11.18	ASNS Turning Heads, SPHS To Report Data In Dec., Mark Your Calendar For COCP (RTTNews)
08.06.18	Aethlon Medical Announces Fiscal 2018 Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Aethlon Medical Aktie VALOR 27832104 / ISIN US00808Y2081

Nachrichten zu Aethlon Medical Inc

Aktien Top/Flop

Meistgelesene Nachrichten